WinterTech is almost one month away, and we’re extremely excited about the final agenda. The 2018 edition of WinterTech will be not only be focusing on the new investment treads in digital health, but will take a in-depth look into the revolution in choice within the consumer landscape and the rapid development of digital therapeutics.
Our jam-packed 1-day conference includes:
- Keynote presentation on how to create seamless health care experiences to meet the needs of consumers by Mark Ganz, CEO of Cambia Health.
- Panel discussion on the opportunities, roadblocks, and regulations within the field of digital therapeutics by Bakul Patel, Associate Director for Digital Health at the FDA.
- Investment Strategies Past and Present: a look into 2017 trends, surprises, and flops. plus predictions for 2018 by VC firms GE Ventures, Canaan, Fifty Years, NEA, and B Capital Group.
- Fireside chat between 4 VCs and their CEOs on their relationship and investment models
- Access to the Investor Breakfast where start-ups and investors discuss business models and explore portfolios. Start-ups apply here.
- Live demos from some of the most innovative companies in the digital healthcare space.
Don’t miss out the hottest digital healthcare event focusing on investment in the space. Register today to take advantage of the early bird rate before prices increase after Friday, December 22nd.
Seems the agenda is susceptible to a continued preoccupation with an assumption that the current evolution of the business model for digital health science will be manageable beyond 2-3 years. It is likely that the national funding for EHR related investments or research could be sharply reduced, since essentially none of this funding has shown a substantial improvement in our nation’s cost and quality of HEALTHcare.
Since our nation’s level of ^ health spending ^ is unsustainable, I would advise everyone to be forewarned that medical education funding could be tied to a medical school, Congressional mandate to gradually change the Federal funding of medical education from free money, aka Medicare, to a requirement that the medical schools solve the cost and quality problems of our nation’s healthcare. In return, the medical schools would receive 5% of every $1 Billion “3 year to date” decrease in national ^ health spending.^ Congress could appoint the ASSOCIATION OF AMERICAN MEDICAL COLLEGES (AAMC) to distribute the risk-sharing funds to their member institutions.
The dollars would be a little odd since the Federal government is responsible to pay 40% of our nation’s health spending. So a decrease in national ^ health spending ^ of $1 Billion, would mean a decrease of $400 million or 10% of last year’s $400 Billion ^ health spending ^ obligation to the Federal government. 5% of a $1 Billion decrease in national ^ health spending ^ represents a $ 2 Million obligation to medical school funding, or 1% of the decrease in Federal ^ health spending. ^ Eventually, the other obligations of the Federal government for support of medical education could be phased out with the assumption that the risk-sharing payments would eventually support under-gradate medical education as well. The current Federal, financial support of medical education would be phased out over three years beginning the fourth year of the risk-sharing associated change in medical education funding.
Current Federal funding of medical education plus related research is ~$20-25 Billion. When national ^ health spending ^ reached 13% of the GDP the relative decrease in the expense to the Federal government would reach $ 400 Billion and the medical school risk sharing would reach $50 Billion minus current Obligations of ~$20-25 Billion. This result could also include an obligation of the AAMC to assure that enhanced Primary Healthcare is uniformly and equitably available to each citizen that is nationally promoted with a community by community strategy similar to the Cooperative Extension Service currently in place for our nation’s agriculture industry since 1914.